FI750014A7 - - Google Patents

Info

Publication number
FI750014A7
FI750014A7 FI750014A FI750014A FI750014A7 FI 750014 A7 FI750014 A7 FI 750014A7 FI 750014 A FI750014 A FI 750014A FI 750014 A FI750014 A FI 750014A FI 750014 A7 FI750014 A7 FI 750014A7
Authority
FI
Finland
Application number
FI750014A
Other languages
Finnish (fi)
Other versions
FI54053B (fi
FI54053C (fi
Inventor
H Bachmayer
G Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI750014A7 publication Critical patent/FI750014A7/fi
Publication of FI54053B publication Critical patent/FI54053B/fi
Application granted granted Critical
Publication of FI54053C publication Critical patent/FI54053C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FI750014A 1974-01-14 1975-01-06 Foerfarande foer isolering av hemagglutinin- och neuraminidasbestaondsdelarna ur ett influensavirus FI54053C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (enExample) 1974-01-14 1974-01-14

Publications (3)

Publication Number Publication Date
FI750014A7 true FI750014A7 (enExample) 1975-07-15
FI54053B FI54053B (fi) 1978-06-30
FI54053C FI54053C (fi) 1978-10-10

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
FI750014A FI54053C (fi) 1974-01-14 1975-01-06 Foerfarande foer isolering av hemagglutinin- och neuraminidasbestaondsdelarna ur ett influensavirus

Country Status (27)

Country Link
JP (2) JPS58407B2 (enExample)
AT (1) AT345449B (enExample)
AU (1) AU500250B2 (enExample)
BE (1) BE824372A (enExample)
CA (1) CA1049406A (enExample)
CH (1) CH589453A5 (enExample)
CS (1) CS191254B2 (enExample)
DD (1) DD116239A5 (enExample)
DE (1) DE2500785B2 (enExample)
DK (1) DK140003B (enExample)
ES (1) ES433759A1 (enExample)
FI (1) FI54053C (enExample)
FR (1) FR2257305B1 (enExample)
GB (1) GB1498261A (enExample)
HK (1) HK56380A (enExample)
HU (1) HU173920B (enExample)
IE (1) IE40794B1 (enExample)
IL (1) IL46426A (enExample)
MY (1) MY8100204A (enExample)
NL (1) NL166622C (enExample)
NO (1) NO143128C (enExample)
PH (1) PH14458A (enExample)
PL (1) PL93689B1 (enExample)
SE (1) SE427238B (enExample)
SU (1) SU616997A3 (enExample)
YU (1) YU41289B (enExample)
ZA (1) ZA75259B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ATE494906T1 (de) * 2005-11-01 2011-01-15 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
JP5535910B2 (ja) * 2007-08-28 2014-07-02 バクスター・インターナショナル・インコーポレイテッド ウイルスワクチンを生産する方法
CA2930634C (en) 2013-11-15 2023-05-09 Novartis Ag Removal of influenza nuclear protein (np) from influenza virus preparations

Also Published As

Publication number Publication date
NO750031L (enExample) 1975-08-11
JPS50100224A (enExample) 1975-08-08
ATA21475A (de) 1978-01-15
DK140003C (enExample) 1979-10-29
NL7500301A (nl) 1975-07-16
YU5875A (en) 1984-04-30
CA1049406A (en) 1979-02-27
CS191254B2 (en) 1979-06-29
HU173920B (hu) 1979-09-28
DE2500785B2 (de) 1980-01-03
IL46426A0 (en) 1975-04-25
JPS58407B2 (ja) 1983-01-06
IL46426A (en) 1978-01-31
BE824372A (fr) 1975-07-14
SE427238B (sv) 1983-03-21
NL166622B (nl) 1981-04-15
NO143128B (no) 1980-09-15
FR2257305A1 (enExample) 1975-08-08
SU616997A3 (ru) 1978-07-25
JPS6035326B2 (ja) 1985-08-14
DD116239A5 (enExample) 1975-11-12
AT345449B (de) 1978-09-11
DE2500785C3 (enExample) 1980-09-11
MY8100204A (en) 1981-12-31
CH589453A5 (enExample) 1977-07-15
HK56380A (en) 1980-10-16
IE40794L (en) 1975-07-14
PL93689B1 (enExample) 1977-06-30
NO143128C (no) 1980-12-29
DE2500785A1 (de) 1975-07-31
IE40794B1 (en) 1979-08-15
FI54053B (fi) 1978-06-30
ZA75259B (en) 1976-08-25
FR2257305B1 (enExample) 1982-03-19
DK140003B (da) 1979-06-05
SE7500130L (enExample) 1975-07-15
PH14458A (en) 1981-07-29
JPS56127319A (en) 1981-10-06
NL166622C (nl) 1981-09-15
AU7730575A (en) 1976-07-15
FI54053C (fi) 1978-10-10
AU500250B2 (en) 1979-05-17
DK1475A (enExample) 1975-09-01
YU41289B (en) 1987-02-28
GB1498261A (en) 1978-01-18
ES433759A1 (es) 1977-02-16

Similar Documents

Publication Publication Date Title
DK141479C (enExample)
DK140730C (enExample)
FR2257305B1 (enExample)
CS167780B1 (enExample)
DK99375A (enExample)
CS177553B1 (enExample)
CS169453B1 (enExample)
CS170688B1 (enExample)
CS171954B1 (enExample)
CS167177B1 (enExample)
CS169571B1 (enExample)
CS168714B1 (enExample)
CH591240A5 (enExample)
CH567542A5 (enExample)
CH592340A5 (enExample)
CH606860A5 (enExample)
CH576726A5 (enExample)
CH591051A5 (enExample)
CH611880A5 (enExample)
CH1584874A4 (enExample)
CH602676A5 (enExample)
CH596633A5 (enExample)
BG27062A1 (enExample)
CH613620A5 (enExample)
CH570912A5 (enExample)

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: DUPHAR INTERNATIONAL RESEARCH B.V